Skip to main content

drug discovery Archives

Drug-like molecules aimed at improving treatment of Parkinson’s

Sep. 30, 2011—Drug-like molecules described by Vanderbilt researchers could lead to Parkinson's treatments with fewer side effects.

Read more


New drug-like molecules could improve schizophrenia treatment

Sep. 22, 2011—The discovery of new compounds that work in a fundamentally different way than those in existing schizophrenia medications may allow for more normal function of brain cells involved in schizophrenia.

Read more


Milestone in development of new treatment for ‘fragile X’

Sep. 15, 2011—Researchers at Vanderbilt University Medical Center, in collaboration with Seaside Therapeutics in Cambridge, Mass., have achieved a milestone in the development of a potential new treatment for fragile X syndrome, the most common genetic cause of autism.

Read more


Nashville innovations

Aug. 23, 2011—Last week when the Nashville Scene’s annual Innovations Issue hit the newsstands, three of its ten “forward-thinking ideas that are pushing Nashville – and the world – into the future” came from Vanderbilt. The three campus projects that impressed the Scene editors were: Digging for Drugs: Cave Chemistry. This is an effort of Associate Professor...

Read more


Discovery of how G proteins ‘turn on’ may lead to better drugs

Aug. 18, 2011—Researchers have discovered how key proteins are “turned on” and transmit signals inside the cell. The discovery could lead to new, more effective drugs.

Read more


New laser technique opens doors for drug discovery

Mar. 14, 2011—A new laser technique can measure interactions between proteins tangled in a cell's membrane and a variety of other biological molecules: extremely difficult measurements that can aid the process of drug discovery.

Read more


Neuroscience drug discovery center opens at Vanderbilt

Mar. 11, 2011—Vanderbilt University Medical Center has established a new Center for Neuroscience Drug Discovery to accelerate research that may lead to new treatments for Parkinson's disease, schizophrenia and other disorders of the brain.

Read more


A new prescription for drug discovery

Feb. 3, 2011—Researchers at Vanderbilt University are busy building the pharmacy of the future. On its shelves may be: • New medications for schizophrenia and Parkinson’s disease, and the first drug treatment for Fragile X syndrome; • A drug that can stop a particularly vicious form of breast cancer in its tracks; • A replacement for acetaminophen...

Read more


Scripps Research and Vanderbilt launch joint institute to advance science at interface of chemistry and medicine

Jan. 13, 2011—The Scripps Research Institute and Vanderbilt University have formed a partnership to advance science at the interface of chemistry and medicine, the institutions announced today. The Human Chemical Sciences Institute will encompass research and training activities at Scripps Research on its San Diego, California, and Jupiter, Florida, campuses, and at the Vanderbilt Institute for Chemical...

Read more


Page 4 of 41234